Search research articles
Contact Us
Filters
Showing results (21-30 of 162) with videos related to
Page
of 17
Sort By:
International Journal of Molecular Sciences
|
September 13, 2025
Altered Lipid Metabolism in CNS Demyelination and Remyelination Are Key Elements Driving Progressive MS
Agata Matejuk, Szymon Matejuk, Halina Offner, et al.
International Immunology
|
February 3, 2007
Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)
Magdalena J Polanczyk, Corwyn Hopke, Arthur A Vandenbark, et al.
BMC Immunology
|
April 21, 2010
GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol
Melissa A Yates, Yuexin Li, Peter J Chlebeck, et al.
Neurochemistry International
|
November 5, 2016
Partial MHC class II constructs as novel immunomodulatory therapy for stroke
Gil Benedek, Arthur A Vandenbark, Nabil J Alkayed, et al.
Immunology
|
November 3, 2011
Regulatory T cells play a role in T-cell receptor CDR2 peptide regulation of experimental autoimmune encephalomyelitis
Abigail C Buenafe, Shayne Andrew, Halina Offner, et al.
Journal of Neuroscience Research
|
May 6, 2006
Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway
Magdalena J Polanczyk, Corwyn Hopke, Arthur A Vandenbark, et al.
Journal of Neuroinflammation
|
January 27, 2019
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
Arthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Investigative Ophthalmology & Visual Science
|
May 26, 2006
Treatment of autoimmune anterior uveitis with recombinant TCR ligands
Grazyna Adamus, Gregory G Burrows, Arthur A Vandenbark, et al.
Metabolic Brain Disease
|
December 1, 2022
PD-L1 is required for estrogen-induced protection against severe EAE in IL-10 deficient mice<sup>1</sup>
Halina Offner, Denesa Lockwood, Roberto Meza-Romero, et al.
Autoimmunity
|
March 23, 2002
Inhibitory effects of incomplete Freund's adjuvant on experimental autoimmune encephalomyelitis
Alex Zamora, Agata Matejuk, Marc Silverman, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 162) with videos related to
Sort By:
Page
of 17
International Journal of Molecular Sciences
|
September 13, 2025
Altered Lipid Metabolism in CNS Demyelination and Remyelination Are Key Elements Driving Progressive MS
Agata Matejuk, Szymon Matejuk, Halina Offner, et al.
International Immunology
|
February 3, 2007
Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)
Magdalena J Polanczyk, Corwyn Hopke, Arthur A Vandenbark, et al.
BMC Immunology
|
April 21, 2010
GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol
Melissa A Yates, Yuexin Li, Peter J Chlebeck, et al.
Neurochemistry International
|
November 5, 2016
Partial MHC class II constructs as novel immunomodulatory therapy for stroke
Gil Benedek, Arthur A Vandenbark, Nabil J Alkayed, et al.
Immunology
|
November 3, 2011
Regulatory T cells play a role in T-cell receptor CDR2 peptide regulation of experimental autoimmune encephalomyelitis
Abigail C Buenafe, Shayne Andrew, Halina Offner, et al.
Journal of Neuroscience Research
|
May 6, 2006
Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway
Magdalena J Polanczyk, Corwyn Hopke, Arthur A Vandenbark, et al.
Journal of Neuroinflammation
|
January 27, 2019
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
Arthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Investigative Ophthalmology & Visual Science
|
May 26, 2006
Treatment of autoimmune anterior uveitis with recombinant TCR ligands
Grazyna Adamus, Gregory G Burrows, Arthur A Vandenbark, et al.
Metabolic Brain Disease
|
December 1, 2022
PD-L1 is required for estrogen-induced protection against severe EAE in IL-10 deficient mice<sup>1</sup>
Halina Offner, Denesa Lockwood, Roberto Meza-Romero, et al.
Autoimmunity
|
March 23, 2002
Inhibitory effects of incomplete Freund's adjuvant on experimental autoimmune encephalomyelitis
Alex Zamora, Agata Matejuk, Marc Silverman, et al.
Page
of 17